| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.00B | +0.4% |
| R&D Expense | $32.8M | +3.3% |
| SG&A Expense | $429.9M | +1.8% |
| Operating Income | $254.5M | -15.0% |
| Interest Expense | $92.4M | -27.0% |
| Pre-tax Income | $193.4M | +15.3% |
| Income Tax | $54.4M | -4.7% |
| Net Income | $138.9M | +25.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $653.1M | +52.2% |
| Short-term Investments | $799.8M | -6.4% |
| Accounts Receivable | $236.3M | +29.8% |
| Inventory | $123.0M | +19.5% |
| Current Assets | $1.96B | +12.7% |
| Total Assets | $4.82B | +1.6% |
| Current Liabilities | $613.9M | +10.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $538.9M | -18.6% |
| Capital Expenditures | $239.4M | -19.2% |
| Investing Cash Flow | -$209.2M | -906.4% |
| Financing Cash Flow | -$103.1M | +89.6% |
| Free Cash Flow | $299.4M | -18.2% |
| Long-term Debt |
| $1.50B |
| +0.1% |
| Total Liabilities | $2.67B | -0.1% |
| Stockholders' Equity | $2.05B | +2.1% |